Hergenrother Lab

Home Research
  • Complex Molecule Synthesis
  • Anticancer Compounds
  • Antibacterial Compounds
News Publications Group Members
  • Prof. Hergenrother
  • Post Docs
  • Graduate Students
  • Undergraduate Students
  • Visiting Scientists
  • Alumni
Group Business
  • Group Jobs
  • Group Meeting Schedule
  • Dissertations
Group Photos Resources & Links Misc.
  • Compound Collection
  • Funding
  • UIUC Affiliations
Site Header Image

The FDA grants Orphan Drug Designation to PAC-1!

Posted on May 24, 2016July 1, 2021 by Lisa Williamson

Human trials of cancer drug PAC-1 continue with new investment.

University of Illinois chemistry professor Paul Hergenrother, right, and veterinary clinical medicine professor Timothy Fan tested an anti-cancer compound in pet dogs that is now being used in human clinical trials.

Posted in PAC-1

Post navigation

Previous: PAC-1 shows efficacy in dog trial
Next: Congratulations to Dr. Sarah Tasker for being awarded a postdoctoral fellowship

Hergenrother Lab

261 Roger Adams Lab

600 S. Mathews Avenue

Urbana, IL, 61802

Email: hergenro@illinois.edu

Department of Chemistry
at the University of Illinois

Go to top